Rhode Island Diastolic Dysfunction - Heart Failure

Completed · Not applicable

Conditions studied: Heart Failure, Cardiovascular Disease

In brief

To study the hypothesis that treating patients with underlying diastolic dysfunction with oral Kuvan® (BH4, also known as tetrahydrobiopterin) in addition to current best practices will improve metabolic and echocardiographic diastolic function parameters.

Key facts

Study ID
NCT02353312
Run by
Providence VA Medical Center
People needed
28
Starts
2015-03-01
Expected to finish
2018-12-01
Last updated by the study team
2025-07-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.